Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

41.61
-1.1500-2.69%
Volume:32.82K
Turnover:1.37M
Market Cap:4.52B
PE:-22.49
High:42.46
Open:42.45
Low:41.48
Close:42.76
52wk High:48.40
52wk Low:13.69
Shares:108.60M
Float Shares:88.17M
Volume Ratio:0.68
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8502
EPS(LYR):-1.6302
ROE:-38.03%
ROA:-25.03%
PB:10.09
PE(LYR):-25.52

Loading ...

Press Release: Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications

Dow Jones
·
May 07

Why Edgewise Therapeutics (EWTX) Is Up 21.5% After Positive Trial, FDA Updates And Equity Grants

Simply Wall St.
·
May 07

Guggenheim Reaffirms Their Buy Rating on Edgewise Therapeutics (EWTX)

TIPRANKS
·
May 06

Wedbush Adjusts Price Target on Edgewise Therapeutics to $46 From $32, Maintains Outperform Rating

MT Newswires Live
·
May 06

Edgewise CMO Joanne M. Donovan disposes of common shares worth $2.09 million

Reuters
·
May 06

Edgewise Therapeutics rises 23.3%

TIPRANKS
·
May 05

BRIEF-Edgewise Therapeutics Reports Inducement Grants As Permitted By The Nasdaq Listing Rules

Reuters
·
May 04

Edgewise Therapeutics grants inducement stock options for 266,000 shares at $30.96 each

Reuters
·
May 04

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
May 04

Edgewise Therapeutics (EWTX) Valuation Check After Strong Multi Year Shareholder Returns

Simply Wall St.
·
Apr 25

Edgewise Therapeutics Faces Near-Term Upside From Cytokinetics' Upcoming Readout, RBC Says

MT Newswires Live
·
Apr 25

Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest

Simply Wall St.
·
Apr 06

Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data

Simply Wall St.
·
Apr 04

Edgewise CMO Joanne Donovan disposes of 28,662 shares for $0.93 million

Reuters
·
Apr 03

Edgewise Therapeutics grants inducement stock options for 72,000 shares to new hires

Reuters
·
Apr 01

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Apr 01

Edgewise CMO Joanne Donovan disposes of $685k common shares

Reuters
·
Apr 01

Top Executive’s Move at Edgewise Therapeutics Sparks Investor Buzz

TIPRANKS
·
Mar 31

Edgewise CMO Joanne Donovan disposes of $1.3 million common shares

Reuters
·
Mar 31

Edgewise Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 17